SCHEMBL4551368

SCHEMBL4551368

Cc1ncc(Nc2cc(F)cc(N3CCOCC3)c2)cc1-c1cc(C(=O)NCC(C)(C)C)n(C)n1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 19/20 0.46
BRAF P15056 19/20 0.46
PLAU P00749 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551369 0.89 RAF1 (0.53) RAF1BRAF
SCHEMBL5602958 0.87 RAF1 (0.45) RAF1BRAFPLAU
SCHEMBL5603871 0.85 BRAF (0.41) RAF1BRAFPLAU
SCHEMBL5604506 0.83 PLAU (0.40) RAF1BRAFPLAU
SCHEMBL5602980 0.77 RAF1 (0.54) RAF1BRAF
SCHEMBL14473165 0.75 RAF1 (0.48) RAF1BRAFPLAU
SCHEMBL4541536 0.75 BRAF (0.43) RAF1BRAFPLAU
SCHEMBL4408603 0.74 RAF1 (0.48) RAF1BRAF
SCHEMBL5592994 0.74 RAF1 (0.48) RAF1BRAF
SCHEMBL5601602 0.73 RAF1 (0.43) RAF1BRAFPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed